Compounds > isosorbide dinitrate
Page last updated: 2024-08-17

isosorbide dinitrate and Carcinoma, Non-Small Cell Lung

isosorbide dinitrate has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, G; Iwasaki, T; Kondo, N; Nakagawa, Y; Ohnishi, T; Su, X; Takahashi, A1
Han, JY; Kim, HT; Kim, HY; Lee, JS; Nam, BH; Yoon, SJ1

Trials

1 trial(s) available for isosorbide dinitrate and Carcinoma, Non-Small Cell Lung

ArticleYear
A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Irinotecan; Isosorbide Dinitrate; Lung Neoplasms; Male; Middle Aged; Nitroglycerin; Treatment Outcome

2012

Other Studies

1 other study(ies) available for isosorbide dinitrate and Carcinoma, Non-Small Cell Lung

ArticleYear
Nitric oxide radical-induced radioadaptation and radiosensitization are G2/M phase-dependent.
    Journal of radiation research, 2011, Volume: 52, Issue:5

    Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Chromosome Aberrations; G2 Phase Cell Cycle Checkpoints; Genes, p53; Humans; Isosorbide Dinitrate; Lung Neoplasms; Nitric Oxide; Nitric Oxide Donors; Radiation Tolerance

2011